The Future of Bacterial Endotoxin Testing

Thursday, July 21, 2022
  • <<
  • >>

Traditional LAL reagents are currently the only FDA licensed reagents for Bacterial Endotoxin Testing (BET); however, a new recombinant alternative – recombinant cascade reagent (rCR) was recently introduced, providing the sustainable benefits and none of the drawbacks of Recombinant Factor C (rFC) reagents. Many early adopters have already implemented rCR for in house BET testing, especially for in process water samples. Download this infographic to learn more about the future of BET methods, and a table comparing the expected attributes from traditional LAL reagent, rFC, and rCR.

 The Future of Bacterial 
Endotoxin Testing

Download Now

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.